Adam Kovalčík, age 19, innovated a cheaper, faster way to produce an antiviral drug. Galidesivir targets RNA viruses like COVID-19, Ebola, and Zika but hasn't completed clinical trials. Kovalčík won a ...
An international team of researchers led by the University of California San Diego has developed a new strategy to enhance ...
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Drugmakers told the FDA that inflexible post-approval change requirements are among the top regulatory barriers to the ...
The U.S. Food and Drug Administration has awarded the National Institute for Pharmaceutical Technology and Education a grant worth up to $35 million over the next five years to improve drug ...
Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback